There was no significant association between DNMT −149C/T polymorphism and the risk of cancer (CC vs. TT: OR 0.96, 95 % CI 0.86–1.09; P = 0.1, I2 = 34 % for heterogeneity). This evidence concerns the gene DNMT1 and cancer.